v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net earnings $ 96,458 $ 94,371
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 64,617 60,615
Impairment losses – real estate, net of recoveries 1,512 1,204
Amortization of notes payable discount 791 661
Amortization of debt costs 1,466 1,301
Amortization of interest rate hedges 460 632
Gain on disposition of real estate (3,813) (4,821)
Performance incentive plan expense 5,637 3,897
Performance incentive plan payment (1,702) (1,274)
Change in operating assets and liabilities, net of assets acquired and liabilities assumed:    
Decrease (increase) in receivables (602) 80
Decrease (increase) in accrued rental income (509) 36
Increase in other assets 1,326 303
Increase in accrued interest payable 44,999 41,113
Increase in other liabilities (7,392) (7,148)
Other 34 (255)
Net cash provided by operating activities 203,282 190,715
Cash flows from investing activities:    
Proceeds from the disposition of real estate 15,935 18,940
Additions to real estate (231,508) (116,406)
Principal payments received on mortgages and notes receivable 460 120
Other (189) (386)
Net cash used in investing activities (215,302) (97,732)
Cash flows from financing activities:    
Proceeds from line of credit payable 249,500 152,000
Repayment of line of credit payable (133,200) (167,800)
Payment of debt issuance costs (53) (53)
Proceeds from issuance of common stock 655 21,693
Stock issuance costs (85) (166)
Payment of common stock dividends (108,335) (102,684)
Net cash provided by (used in) financing activities 8,482 (97,010)
Net increase (decrease) in cash, cash equivalents and restricted cash [1] (3,538) (4,027)
Cash, cash equivalents and restricted cash at beginning of period [1] 9,062 5,155
Cash, cash equivalents and restricted cash at end of period [1] 5,524 1,128
Supplemental disclosure of cash flow information:    
Interest paid, net of amount capitalized 928 2,221
Supplemental disclosure of noncash investing and financing activities:    
Change in other comprehensive income 168 632
Change in work in progress accrual $ 885 $ 8,086
[1]

Cash, cash equivalents and restricted cash is the aggregate of cash and cash equivalents and restricted cash and cash held in escrow from the Condensed Consolidated Balance Sheets. As of March 31, 2025 and December 31, 2024, NNN had restricted cash of $427 and $331, respectively. NNN did not have restricted cash and cash held in escrow as of March 31, 2024.